"El IUC tiene como misión desarrollar la docencia universitaria, la investigación y la extensión para: • la formación integral de profesores y alumnos, promoviendo valores y actitudes vitales que hacen a la tradición humanística de la cultura universal; • en un ambiente válido que estimule la búsqueda de enfoques integradores partiendo de la diversidad y del pluralismo; • buscando el equilibrio entre las tradiciones y las innovaciones y entre el desarrollo armónico de la mente y el cuerpo; y • estimulando a los estudiantes a lograr una permanente actualización y perfeccionamiento a través de su propio interés y esfuerzo."

During the past decade, CEMIC (Centro de Educación Médica e Investigaciones Clínicas) conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CEMIC (Centro de Educación Médica e Investigaciones Clínicas)" #1 sponsor was "Janssen Research & Development, LLC" with 4 trials, followed by "Bio Products Laboratory" with 1 trials sponsored, "Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno" with 1 trials sponsored, "Fundacion GESICA" with 1 trials sponsored and "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CEMIC (Centro de Educación Médica e Investigaciones Clínicas)" #1 collaborator was "Applied Health Research Centre" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator and "University of Toronto" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "CEMIC (Centro de Educación Médica e Investigaciones Clínicas)" are "ARDS" (1 trials), "Advanced or Metastatic Non-small Cell Lung Cancer" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Chronic Idiopathic Thrombocytopenic Purpura" (1 trials) and "Colitis, Ulcerative" (1 trials). Many other conditions were trialed in "CEMIC (Centro de Educación Médica e Investigaciones Clínicas)" in a lesser frequency.

Most popular intervention types in "CEMIC (Centro de Educación Médica e Investigaciones Clínicas)" are "Drug" (6 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lazertinib" (2 trials), "Placebo" (2 trials), "Amantadine, Ribavirin, Oseltamivir" (1 trials), "Amivantamab" (1 trials) and "Amivantamab Intravenous" (1 trials). Other intervention names were less common.

The vast majority of trials in "CEMIC (Centro de Educación Médica e Investigaciones Clínicas)" are 9 trials for "All" genders.

Currently, there are NaN active trials in "CEMIC (Centro de Educación Médica e Investigaciones Clínicas)". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in CEMIC (Centro de Educación Médica e Investigaciones Clínicas), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CEMIC (Centro de Educación Médica e Investigaciones Clínicas), 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".